CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state-of-the art production facilities.

News Releases

News Releases

CV Sciences, Inc. Appoints Dr. Stephen M. Schmitz to its Board of Directors

Highly Regarded Pharma Veteran with Extensive Expertise in Drug Safety, Dietary Supplement Safety, Clinical Development and Regulatory Affairs LAS VEGAS, NV – (Marketwired – May 16, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (“CV Sciences,” “our” or “we”), today announced the appointment of Stephen M. Schmitz, MD, MPH to its Board of Directors effective May … Continue reading CV Sciences, Inc. Appoints Dr. Stephen M. Schmitz to its Board of Directors

CV Sciences, Inc. Highlights WHO’s World No Tobacco Day – May 31, 2017

LAS VEGAS, NV – (Marketwired – May 8, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), is pleased to highlight the World Health Organization (WHO) and its partners in the annual World No Tobacco Day on May 31, 2017. The day notably features the health and risks associated with … Continue reading CV Sciences, Inc. Highlights WHO’s World No Tobacco Day – May 31, 2017

CV Sciences, Inc. Launches First Online Education Platform for Retail Sales Associates and Industry Professionals

Company expands hemp-derived CBD education efforts and builds expertise and brand advocacy amongst its growing number of wholesale and retailer partners   LAS VEGAS, NV–(Marketwired – March 13, 2017) – CV Sciences, Inc., (OTCBB: CVSI) preeminent supplier and manufacturer of hemp-derived CBD oil bulk and consumer products, today announced the launch of the first online … Continue reading CV Sciences, Inc. Launches First Online Education Platform for Retail Sales Associates and Industry Professionals

CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil™, at Natural Products Expo West in Anaheim, CA – March 9-12, 2017

Company will be launching new products, hosting an interactive presentation, providing retailer education, and offering giveaways and show specials to natural health retailers attending the show LAS VEGAS, NV–(Marketwired – February 28, 2017) – CV Sciences, Inc. (OTCBB: CVSI), leading supplier and manufacturer of hemp-derived CBD oil, announces that its industry dominating brand of hemp-derived … Continue reading CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil™, at Natural Products Expo West in Anaheim, CA – March 9-12, 2017

CV Sciences, Inc. to Present at NobleCon13 Annual Investor Conference

LAS VEGAS, NV–(Marketwired – January 25, 2017) – CV Sciences, Inc. (OTCBB: CVSI) (the “Company”), announced today that it will be presenting at the NobleCon13 Annual Investor Conference to be held January 30-31, 2017 at the Boca Raton Resort & Club, Florida. Event: NobleCon13 Annual Investor Conference Location: Boca Raton Resort & Club – Boca … Continue reading CV Sciences, Inc. to Present at NobleCon13 Annual Investor Conference

CV Sciences, Inc. to Present at 9th Annual Biotech Showcase

LAS VEGAS, NV–(Marketwired – December 22, 2016) – CV Sciences, Inc. (OTCBB: CVSI) (the “Company”), announced today that it will be presenting at the 9th Annual Biotech Showcase to be held January 9-11, 2017 at the Hilton San Francisco Union Square in San Francisco, CA. Event: 9th Annual Biotech Showcase Location: Hilton San Francisco Union … Continue reading CV Sciences, Inc. to Present at 9th Annual Biotech Showcase

CV Sciences, Inc. Highlights Major League Baseball (MLB) Decision to Prohibit All New Players From Using Smokeless Tobacco

LAS VEGAS, NV–(Marketwired – December 20, 2016) – CV Sciences, Inc. (OTCBB: CVSI) (the “Company”, “CV Sciences”, “our” or “we”), today provided comments from its management with regards to the MLB’s recent ban on smokeless chewing tobacco for new players. Beginning this upcoming season, cities that include San Francisco, Boston, and Los Angeles will ban … Continue reading CV Sciences, Inc. Highlights Major League Baseball (MLB) Decision to Prohibit All New Players From Using Smokeless Tobacco

CV Sciences, Inc. Provides Details for Webcast Discussing Its CBD- Based Drug Development Program on November 10, 2016

Company to Discuss Development Efforts and Market Potential of its Proprietary Lead Drug Candidate, CVSI-007 Las Vegas, Nevada, November 3, 2016 – CV Sciences, Inc. (OTCBB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) will hold a webcast on Thursday, November 10, 2016 at 5:00PM Eastern Standard Time to discuss its drug development program and specifically … Continue reading CV Sciences, Inc. Provides Details for Webcast Discussing Its CBD- Based Drug Development Program on November 10, 2016

CV Sciences, Inc. to Host Webcast on its CBD-based Drug Development Program on November 10, 2016

Source: MarketWired Company to Discuss Advances in Program for Development of Therapeutic Products for Cessation of Smokeless Tobacco Use and Addiction — A Market Estimated to Exceed $2 Billion in the U.S. LAS VEGAS, NV–(Marketwired – October 28, 2016) – CV Sciences, Inc. (OTCBB: CVSI) (the “Company”) today announced that it will hold a webcast … Continue reading CV Sciences, Inc. to Host Webcast on its CBD-based Drug Development Program on November 10, 2016